Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
Novello, S, Bruzzi, P, Barone, C, Buosi, R, Masotti, A, Michetti, G, Fioretti, M, Barbera, S, Spatafora, M, Garetto, L, Mazzanti, P, Dongiovanni, V, Selvaggi, G, Crino, L, Scagliotti, G.Volume:
18
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm061
Date:
February, 2007
File:
PDF, 122 KB
english, 2007